Analysis Sans Frontières: Can We Ever Make Economic Evaluations Generalisable Across Jurisdictions?

Author： Sculpher Mark J.   Drummond Michael F.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.11, 2006-01, pp. : 1087-1099

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hospital Selection for Unit Cost Estimates in Multicentre Economic Evaluations: Does the Choice of Hospitals Make a Difference?

By Goeree R.  

PharmacoEconomics, Vol. 15, Iss. 6, 1999-06 ,pp. : 561-572

Adis International

Access to resources Recommend Favorite

Can I make an observation?

By  

Inpharma, Vol. 1, Iss. 1618, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Rosiglitazone and MI risk - will we ever know the answer?

By  

Inpharma, Vol. 1, Iss. 1594, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Can clinical research ever be truly independent?

By  

Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Economic Evaluations During Early (Phase II) Drug Development: A Role for Clinical Trial Simulations?

By Hughes D.A.   Walley T.  

PharmacoEconomics, Vol. 19, Iss. 11, 2001-11 ,pp. : 1069-1077

Adis International

Access to resources Recommend Favorite